4//SEC Filing
Levy Adam Scott 4
Accession 0001933414-25-000130
CIK 0001933414other
Filed
Oct 14, 8:00 PM ET
Accepted
Oct 15, 7:04 PM ET
Size
7.6 KB
Accession
0001933414-25-000130
Insider Transaction Report
Form 4
Levy Adam Scott
CFO and Secretary
Transactions
- Sale
Common Stock
2025-10-13$42.26/sh−3,392$143,333→ 116,865 total - Sale
Common Stock
2025-10-13$41.90/sh−7,366$308,651→ 120,257 total
Footnotes (4)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 14, 2023.
- [F2]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $41.1362 to $42.1300. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.
- [F3]Since the date of the Reporting Person's last ownership report, 5,311 shares of common stock were transferred to an ex-spouse pursuant to a domestic relations order. The Reporting Person no longer reports as beneficially owned any securities owned by his ex-spouse.
- [F4]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $42.1600 to $42.3400. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.
Documents
Issuer
Mineralys Therapeutics, Inc.
CIK 0001933414
Entity typeother
Related Parties
1- filerCIK 0001693134
Filing Metadata
- Form type
- 4
- Filed
- Oct 14, 8:00 PM ET
- Accepted
- Oct 15, 7:04 PM ET
- Size
- 7.6 KB